Catalyst Wire Dossier Catalyst Wire Dossier

ACH-126, 443 (Beta-L-Fd4C)

· Alexion Pharmaceuticals, Inc.
Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for ACH-126, 443 (Beta-L-Fd4C), covering 2009-08-19 to 2021-02-18. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Antiviral Activity Study of ACH-126,443 (Beta-L-Fd4C) in Treatment-naive Adults With Chronic Hepatitis B Virus Infection [Phase 2]

See pricing